Purdue Pharma Settles With States Over OxyContin

Law360, New York (May 8, 2007, 12:00 AM EDT) -- Drug manufacturer Purdue Pharma has agreed to pay 26 states and the District of Columbia $19.5 million to settle allegations that it encouraged doctors to prescribe OxyContin for unapproved uses and did not adequately disclose the potential for abuse of the drug.

The settlement, which still has to be approved by state judges across the country, would also force the company to market and promote the narcotic painkiller effectively, not base the bonuses of sales representatives on the volume of OxyContin prescribed, and use education about...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.